Heineken Holding NV (0NBD)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 74.63 |
|---|---|
| 52-week range | 58.15 – 75.45 |
| Return, 1 month / 3 months | +11.4% / +8.2% |
| Return, 1 year / 3 years | +26.0% / +15.2% |
| Trend | Uptrend |
| RSI (14) | 79 |
| Volatility (1 year) | 21.7% |
| Worst drawdown (1 year) | -18.1% |
| Average daily value traded | 1.20M EUR |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Heineken Holding NV is a Dutch holding company based in Amsterdam whose main purpose is to hold a controlling interest in Heineken NV, the international brewer. Through that stake it is connected to the brewing and marketing of beer and cider brands sold to drinkers in many countries, along with related activities such as distribution and hospitality. The company itself does not brew or sell beer directly; its role is to hold and manage its investment in the brewing group.
On this site Heineken Holding NV appears as a stock on the London Exchange (UK), code 0NBD, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Heineken Holding NV (0NBD) trades on the London Exchange in UK. It last closed at EUR 74.63 on 23 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 435 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.0% and over the last three months it rose 8.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 81 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.5% | ||
| From 52-week high | -0.3% | ||
| Momentum | 75 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.2% | ||
| 6-month return | 27.7% | ||
| 12-month return, skipping the last month | 13.1% | ||
| Stability (higher is calmer) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.1% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.20M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.4% |
|---|---|
| 1 month | +11.4% |
| 3 months | +8.2% |
| 6 months | +27.7% |
| 1 year | +26.0% |
| 3 years | +15.2% |
| 5 years | +9.0% |
Signals
| 50-day / 200-day average | 68.16 / 65.17 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.25 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Aug 2026 | EUR 0.7600 |
| 27 Apr 2026 | EUR 1.1600 |
| 30 Jul 2025 | EUR 0.7400 |
| 23 Apr 2025 | EUR 1.1700 |
| 31 Jul 2024 | EUR 0.6900 |
| 29 Apr 2024 | EUR 1.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.